Lv2
116 积分 2022-12-15 加入
Fifty years of monoclonals: the past, present and future of antibody therapeutics
23小时前
待确认
Trends in First‐in‐Human Studies for Intrathecal Antisense Oligonucleotides: Insights From 2010 to 2024
5天前
已完结
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series
1个月前
已完结
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series
1个月前
已完结
Oligonucleotide-Based Therapeutics for Neurodegenerative Disorders: Focus on Antisense Oligonucleotides
1个月前
已完结
Neuroinflammation in Alzheimer disease
1个月前
已完结
Oligonucleotide-Based Therapeutics for Neurodegenerative Disorders: Focus on Antisense Oligonucleotides
1个月前
已完结
The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trial
2个月前
已完结
Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, in Diabetic Macular Edema
2个月前
已完结
An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript
2个月前
已完结
皖公网安备34019202002308
